NCT05934422Completed
NiPPeR Randomised Trial - Child Follow Up Study
Nutritional Intervention Preconception and During Pregnancy to Maintain Healthy Glucose Metabolism and Offspring Health - Child Health and Well-being Follow Up Study
Source: ClinicalTrials.gov · Last updated 19 Nov 2025
Brief summary (registry, in English)
There is an increasing focus on the need to optimise nutrition, lifestyle and metabolism of parents before and during pregnancy and of the infant after birth, but as yet there is limited understanding of the specific influences and of the underlying mechanisms. This study is a follow up of children from the NiPPeR trial of a nutritional drink enriched with micronutrients, myo-inositol and probiotics taken preconception and during pregnancy. In this setting we will examine the influence of parental nutrition, lifestyle and metabolism before and during pregnancy on child growth, development and well-being; ascertaining growth, adiposity, metabolism, neurobehavioural and health outcomes in the children, and characterising the underlying mechanisms. The data collected will allow identification of the contributions of parental and offspring characteristics, nutritional, lifestyle and medical factors, social and economic status, ethnicity, genetics, metabolism and microbes to promoting healthy growth, body composition and wellbeing in the children.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 461 (actual)
- First submitted
- 4 May 2023
- Start date
- 16 Jun 2023
- Primary completion date
- 14 Aug 2025
- Lead sponsor
- University of Southampton
- Diseases
- Atopic dermatitis (eczema), Obesity
- NCT number
- NCT05934422
What you commit to
- Study type: Interventional
- Participants enrolled: 461
- From 16 Jun 2023 to the primary completion date, 14 Aug 2025
- 3 sites in 3 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Known significant congenital anomaly or genetic condition that influences child growth or neurodevelopment.
Who the study is looking for
- All children still participating in the NiPPeR study at 6-8 years.
Age in the registry: 6 years to 8 years · Sex: All · Accepts healthy volunteers
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Hospital Southampton Coordinator of this site? Confirm its status | Southampton | United Kingdom | Unknown status |
| The University of Auckland Coordinator of this site? Confirm its status | Auckland | New Zealand | Unknown status |
| National University Hospital Coordinator of this site? Confirm its status | Singapore | Singapore | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.